Use this URL to cite or link to this record in EThOS:
Title: The design and synthesis of novel matrix metalloproteinase inhibitors
Author: Franks, Helen Clare
ISNI:       0000 0001 3483 0545
Awarding Body: University of Southampton
Current Institution: University of Southampton
Date of Award: 2005
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Matrix meetalloproteinases (MMPs) are a therapeutic target for many pharmaceutical companies as they are involved in numerous disease areas such as tumour metastasis, rheumatoid arthritis, multiple sclerosis and coronary heart disease. Recently, the ancorinoside natural products were described as micromolar MMP inhibitors. Chapter one describes the synthesis of an array of tetramic acids, the core functional group present in the ancorinosides. The compounds synthesised were then tested in biological assays in order to determine whether any were effective MMP inhibitors. The use of molecular modelling technology in aiding the synthesis of tetramic acids is discussed. In chapter two, keto-pyrrolidinones are introduced as an alternative scaffold to tetramic acids. A series of keto-pyrrolidinones was prepared and tested for MMP activity. The third chapter of my thesis describes synthetic studies directed towards ageladine A, a recently isolated MMP inhibitor. The synthesis of the structure reported for ageladine A was achieved via a Suzuki coupling of the pyrrole and pyridine portions. Analogues of this have been tested for MMP activity.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID:  DOI: Not available